PATENT CLAIM ANALYSIS

Application Number: 16129694
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "181100"]

Abstract:
Disclosed herein are compositions and pharmaceutical formulations that comprise a binding moiety conjugated to a polynucleic acid molecule and a polymer. Also described herein include methods for treating a cancer which utilize a composition or a pharmaceutical formulation comprising a binding moiety conjugated to a polynucleic acid molecule and a polymer.

Claim (Index 19):
The method of  claim 1 , wherein the guide strand hybridizes to a target region of a gene selected from the group consisting of KRAS, EGFR, AR, CTNNB1, PIK3CA, PIK3CB, MYC, and HPRT1.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.65625
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16128440', '14815111', '13872052', '15381972', '15995889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7729085860837125
- 35 USC 102 Novelty (BERT): 0.6643822559230382
- Combined Prediction Score: 0.7620559530676451
- Mean Citation Score: 355.319652
- Max Citation Score: 700.3837
- Similarity Product: 554.9958597690642

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test